Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 246,000 | 357,000 | 191,000 | 217,000 | 571,000 |
| Receivables | 1,233,000 | 1,287,000 | 1,217,000 | 1,307,000 | 1,238,000 |
| Inventories | 989,000 | 949,000 | 926,000 | 897,000 | 895,000 |
| Income taxes - deferred | 303,000 | 320,000 | 279,000 | 288,000 | 536,000 |
| Other current assets | 0 | 0 | 0 | 302,000 | 0 |
| TOTAL | $3,175,000 | $3,214,000 | $2,936,000 | $3,011,000 | $3,525,000 |
| Non-Current Assets | |||||
| PPE Net | 1,522,000 | 1,534,000 | 1,539,000 | 1,546,000 | 1,530,000 |
| Intangibles | 11,633,000 | 11,394,000 | 11,499,000 | 11,643,000 | 11,489,000 |
| Other Non-Current Assets | 388,000 | 335,000 | 361,000 | 371,000 | 373,000 |
| TOTAL | $13,543,000 | $13,263,000 | $13,399,000 | $13,560,000 | $13,392,000 |
| Total Assets | $16,718,000 | $16,477,000 | $16,335,000 | $16,571,000 | $16,917,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 3,000 | 4,000 | 3,000 | 3,000 |
| Accounts payable and accrued liabilities | 234,000 | 241,000 | 241,000 | 246,000 | 238,000 |
| Accrued Expenses | 1,288,000 | 1,277,000 | 1,275,000 | 1,348,000 | 1,346,000 |
| Other current liabilities | 295,000 | 252,000 | 199,000 | 227,000 | 315,000 |
| TOTAL | $1,820,000 | $1,773,000 | $1,719,000 | $1,824,000 | $1,902,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,249,000 | 4,252,000 | 4,245,000 | 4,237,000 | 4,246,000 |
| Other Non-Current Liabilities | 2,724,000 | 2,606,000 | 2,398,000 | 2,569,000 | 2,583,000 |
| TOTAL | $8,197,000 | $8,160,000 | $8,082,000 | $8,208,000 | $8,452,000 |
| Total Liabilities | $10,017,000 | $9,933,000 | $9,801,000 | $10,032,000 | $10,354,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,326,490 | 1,325,708 | 1,322,676 | 1,324,193 | 1,335,221 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -8,389,000 | -8,432,000 | -8,436,000 | -8,570,000 | -8,678,000 |
| Other shareholders' equity | 110,000 | 42,000 | 72,000 | 106,000 | 56,000 |
| TOTAL | $6,701,000 | $6,544,000 | $6,534,000 | $6,539,000 | $6,563,000 |
| Total Liabilities And Equity | $16,718,000 | $16,477,000 | $16,335,000 | $16,571,000 | $16,917,000 |